हिंदी में पढ़ें
Banking & Financial Services
Income Tax Calculator
Personal Loan Calculator
Car Loan Calculator
Home Loan Calculator
Stock investment update: Ace investor Rakesh Jhunjhunwala removes money in this pharma-major - What should you do?
Thu, Jan 17, 2019
Although, the ace investor has removed his money in Lupin on a marginal basis in Q3FY19, what is interesting to know is that this would be his second selling in this company.
Pharma sector outlook 2019 in India: Expect big recovery in New Year; IPCA, Divis Lab champions of 2018
Mon, Dec 31, 2018
The sector has been volatile throughout the year due to constant news flow in the markets. Some giants of the sector witnessed objections over their manufacturing plants and medicine pricing in the U.S. markets.
An intelligent and patient-friendly chatbot is trained to help patients with health-related concerns: Rajeev Sibal, Lupin
Tue, Dec 04, 2018
Indian pharmaceutical market has grown at 10-11% in the last 4-5 years and if you see the growth of Lupin, that it has grown by 16% from 2014 to 2018.
A third of pharmaceutical companies miss Q2 average estimate
Tue, Nov 20, 2018
Almost one-third of the BSE 100 pharmaceutical companies have missed the average estimate in the quarter ended September 2018, pulled down by the lower sales and anti-trust litigation provision.
Lupin gets USFDA nod for generic contraceptive tablets
Wed, Aug 22, 2018
The company has received tentative approval for its Nudovra (Estradiol Valerate Tablets, 3 mg and 1 mg and Estradiol Valerate and Dienogest Tablets, 2 mg/2 mg and 2 mg/3 mg) tablets from the US Food and Drug Administration (FDA), Lupin said in a statement.
Lupin Q1 net profit dips 43 pc at Rs 203 cr
Wed, Aug 08, 2018
Drug firm Lupin today reported 43.37 per cent decline in its consolidated net profit at Rs 202.76 crore for the first quarter ended June 30, hit by drop in sales in the US and Japan
Lupin launches plaque psoriasis treatment spray in US market
Fri, Jul 27, 2018
Drug major Lupin today announced the launch of Desoximetasone Topical Spray, used for treatment of plaque psoriasis, in the US market.
Rakesh Jhunjhunwala changes portfolio; These stocks got Big Bull's thumbs up; reason to buy?
Fri, Jul 20, 2018
Rakesh Jhunjhunwala portfolio: Among 29 stocks where Rakesh Jhunjhunwala holds over 1 per cent stake, three saw his holdings go up. These include Lupin, NCC and Jaiprakash Associates.
Rakesh Jhunjhunwala buys 1 lakh shares of this pharma firm; stock soars
Tue, Jul 17, 2018
Rakesh Jhunjhunwala owned 86,98,605 shares or 1.92 per cent stake in this firm at the end of the March quarter of financial year 2017-18. According to latest shareholding pattern available on the BSE, Jhunjhunwala increased his holding in the company by 1 lakh shares in the June quarter.
As rupee takes a record plunge, these 5 stocks can earn you hefty returns
Thu, Jun 28, 2018
While rupee depreciation doesn't bode well for importers, it brings cheers for exporters who earn their revenues in rupees. We have compiled 5 stocks from export-oriented sectors such as information technology (IT) and pharma sectors for you to look at positively:
Maruti Suzuki, HDFC Bank among top stocks buzzing in Thursday's session
Thu, Jun 14, 2018
Lupin has announced that it has launched Tobramycin Inhalation Solution USP, in the US market. Lupin had already received USFDA approval for Tobramycin Inhalation from the USFDA.
Public sector banks spoil Q3 earnings party on D-Street
Mon, Feb 19, 2018
Stock market investors who were expecting strong overall third-quarter earnings performance have a reason to feel disappointed.
FAST MONEY: SBI, Lupin among top 10 buy and sell ideas for Monday's trade
Mon, Feb 12, 2018
The domestic market are expected to open higher on Monday, tracking Asian markets, which found a semblance of calm as S&P futures extended their bounce, though bond investors were still fretting about the risks from looming US inflation data.
Lupin's consolidated Q3FY18 PAT drops by 65% yoy; shares touch 52-week low
Tue, Feb 06, 2018
Lupin's consolidated PAT more than halved in Q3FY18 to Rs 221.7 crore, down by 65% from Rs 633.1 crore, in the corresponding period of the previous year.
Lupin launches new antibiotic tablet
Fri, Jan 19, 2018
The drug is used for the treatment of infections caused by various microorganisms and as an adjunctive therapy in severe acne
Sensex zooms 195 points on strong global cues
Mon, Dec 11, 2017
Benchmark BSE Sensex advanced by 195 points in early session today on continuous buying by domestic institutional investors amid strong global leads. The NSE Nifty also went past the 10,300-mark.
Sensex climbs over 110 points after Asian uptrend
Thu, Aug 24, 2017
dian stocks today shrugged off weakness in US markets as the Sensex surged over 110 points, with domestic investors doing the job amid positive Asian cues.
10 Indian CEOs who took home salaries up to Rs 60 crore in FY17
Mon, Jul 24, 2017
Zeebiz collates and lists salaries of CEO's in India after a report revealed that higher management earned up to 1200 times more than other employees.
Sensex bounces back by 195 points, Nifty rises above 9,600-mark in early trade
Fri, Jun 02, 2017
The key equity indices of Indian markets- Sensex and Nifty- have resumed their record-setting spree and have recovered to fresh lifetime highs in opening trade on Friday on sustained buying amid positive global cues.
Sun Pharma says sales may fall in 2018 as US market gets tougher for generic drugs
Sat, May 27, 2017
Sun Pharmaceutical Industries MD Dilip Shanghvi has said on Friday that the US sales might fall in 2018 because of pressure on drug prices, signalling tough market conditions in the United States (US) for generic drugmakers.